150 related articles for article (PubMed ID: 15265628)
1. Involvement of nitric oxide-dependent pathways of dorsolateral periaqueductal gray in the effects of ethanol in rats submitted to the elevated plus-maze test.
Morato GS; Ortiga RM; Ferreira VM
Behav Brain Res; 2004 Aug; 153(2):341-9. PubMed ID: 15265628
[TBL] [Abstract][Full Text] [Related]
2. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
3. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide involvement and neural substrates of the conditioned and innate fear as evaluated in the T-maze test in rats.
Calixto AV; Duarte FS; Moraes CK; Faria MS; De Lima TC
Behav Brain Res; 2008 Jun; 189(2):341-9. PubMed ID: 18342958
[TBL] [Abstract][Full Text] [Related]
5. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
6. NOC-9, a selective nitric oxide donor, induces flight reactions in the dorsolateral periaqueductal gray of rats by activating soluble guanylate cyclase.
Braga AA; Aguiar DC; Guimarães FS
Neurosci Lett; 2009 Aug; 459(2):79-83. PubMed ID: 19427360
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of a nitric oxide synthase inhibitor impairs fear sensitization in the plus-maze.
Sakae DY; Pereira LO; da Cunha IC; de Lima TC; Paschoalini MA; Faria MS
Neurobiol Learn Mem; 2008 Sep; 90(2):455-9. PubMed ID: 18621556
[TBL] [Abstract][Full Text] [Related]
8. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
Borelli KG; Brandão ML
Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats.
Ferreira VM; Valenzuela CF; Morato GS
Alcohol Clin Exp Res; 1999 Dec; 23(12):1898-904. PubMed ID: 10630608
[TBL] [Abstract][Full Text] [Related]
10. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
11. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray.
De Luca-Vinhas MC; Macedo CE; Brandão ML
Pain; 2006 Mar; 121(1-2):94-104. PubMed ID: 16472918
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
Martins AP; Marras RA; Guimarães FS
Depress Anxiety; 2000; 12(2):99-101. PubMed ID: 11091933
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
Spolidório PC; Echeverry MB; Iyomasa M; Guimarães FS; Del Bel EA
Psychopharmacology (Berl); 2007 Dec; 195(2):183-92. PubMed ID: 17661019
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
16. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
17. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
[TBL] [Abstract][Full Text] [Related]
18. Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action.
Savegnago L; Jesse CR; Pinto LG; Rocha JB; Barancelli DA; Nogueira CW; Zeni G
Pharmacol Biochem Behav; 2008 Feb; 88(4):418-26. PubMed ID: 17936885
[TBL] [Abstract][Full Text] [Related]
19. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
de Paula Soares V; Zangrossi H
Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
